To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.

Bill 117 hr 6813, titled "To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease," aims to address the potential neurological effects of COVID-19 on individuals who already have a neurological disease.

The bill directs the Secretary of Health and Human Services to conduct a study specifically focused on how COVID-19 may impact individuals with pre-existing neurological conditions. This study will be carried out by the National Institutes of Health, under the guidance of the Director.

The purpose of this study is to better understand the potential neurological impacts of COVID-19 on individuals with neurological diseases, such as Alzheimer's, Parkinson's, multiple sclerosis, and others. By conducting this research, policymakers and healthcare professionals will be better equipped to provide appropriate care and support for individuals who may be at higher risk for neurological complications due to COVID-19. Overall, Bill 117 hr 6813 seeks to gather valuable information on the intersection of COVID-19 and neurological diseases, with the goal of improving outcomes and treatment options for individuals who may be particularly vulnerable to the neurological effects of the virus.